• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

BACLOFEN Drug Record

  • Summary
  • Interactions
  • Claims
  • BACLOFEN chembl:CHEMBL701 Approved

    Alternate Names:

    KEMSTRO
    LYFLEX
    LIORESAL
    BA-34647
    LIORESAL INTRATH
    BACLOSPAS-10
    GABLOFEN
    BACLOFEN

    Drug Info:

    Year of Approval 1977
    Drug Class muscle relaxants
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications for treatment of alcohol dependance
    (3 More Sources)

    Publications:

    Seifert et al., 1998, Effects of baclofen on the Hering-Breuer inspiratory-inhibitory and deflation reflexes in rats., Am. J. Physiol.
    Parramón et al., 1995, GABAB receptors increase intracellular calcium concentrations in chromaffin cells through two different pathways: their role in catecholamine secretion., J. Neurosci. Res.
    Garcia-Gil et al., Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats., Neurotoxicol Teratol
    Mott et al., 1999, GABAB-Receptor-mediated currents in interneurons of the dentate-hilus border., J. Neurophysiol.
    Motalli et al., 1999, GABA(B) receptor activation promotes seizure activity in the juvenile rat hippocampus., J. Neurophysiol.
    Stringer et al., 1999, The reduction in paired-pulse inhibition in the rat hippocampus by gabapentin is independent of GABA(B) receptor receptor activation., Epilepsy Res.
    Lehmann, 2009, GABAB receptors as drug targets to treat gastroesophageal reflux disease., Pharmacol. Ther.
    Pittman, 1999, The action is at the terminal., J. Physiol. (Lond.)
    Bowery, 1993, GABAB receptor pharmacology., Annu. Rev. Pharmacol. Toxicol.
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Ogasawara et al., 1999, Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer., Pharmacol. Biochem. Behav.
    Fu Z et al., 2012, The γ-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens., Behav Brain Funct
    Chen K et al., 2005, Role of GABAB receptors in GABA and baclofen-induced inhibition of adult rat cerebellar interpositus nucleus neurons in vitro., Brain Res Bull
    Takemura et al., 2001, GABA B receptor-mediated effects on expression of c-Fos in rat trigeminal nucleus following high- and low-intensity afferent stimulation., Neuroscience
    Braun et al., 2004, GABAB receptor activation inhibits exocytosis in rat pancreatic beta-cells by G-protein-dependent activation of calcineurin., J. Physiol. (Lond.)
    Belley et al., 1999, Synthesis of the nanomolar photoaffinity GABA(B) receptor ligand CGP 71872 reveals diversity in the tissue distribution of GABA(B) receptor forms., Bioorg. Med. Chem.
    Martin et al., 1999, Molecular identification of the human GABABR2: cell surface expression and coupling to adenylyl cyclase in the absence of GABABR1., Mol. Cell. Neurosci.
    Filippov et al., 2000, Heteromeric assembly of GABA(B)R1 and GABA(B)R2 receptor subunits inhibits Ca(2+) current in sympathetic neurons., J. Neurosci.
    Jones et al., 2000, Signal transduction by GABA(B) receptor heterodimers., Neuropsychopharmacology
    Rawls et al., 2006, Baclofen and NOS inhibitors interact to evoke synergistic hypothermia in rats., Life Sci.
    Rawls et al., 2004, Pronounced hypothermic synergy between systemic baclofen and NOS inhibitor., Eur. J. Pharmacol.
    Passariello et al., 1982, A possible role of gamma-aminobutyric acid in the control of the endocrine pancreas., J. Clin. Endocrinol. Metab.
    Mizoguchi et al., 2006, BDNF occludes GABA receptor-mediated inhibition of GABA release in rat hippocampal CA1 pyramidal neurons., Eur. J. Neurosci.
    Rey-Roldán et al., 1997, In vivo interaction of baclofen, TRH and serotonin on PRL and TSH secretion in the developing and adult male and female rats., Life Sci.
    Hwang et al., 1989, Baclofen, gamma-aminobutyric acidB receptors and substance P in the mouse spinal cord., J. Pharmacol. Exp. Ther.
  • BACLOFEN   GABBR2

    Interaction Score: 16.08

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name ALKS 29
    Novel drug target Established target
    Mechanism of Interaction GABA-B receptor agonist

    PMIDs:
    15235087 10658574 19303900 10328880 10545129 10751439 8388192 11008066 22559224 16182939


    Sources:
    TdgClinicalTrial ChemblInteractions TEND

  • BACLOFEN   GABBR1

    Interaction Score: 15.02

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name ALKS 29
    Novel drug target Established target
    Mechanism of Interaction GABA-B receptor agonist

    PMIDs:
    9486305 7674378 10386831 10482760 10444662 10094428 19303900 10545129 8388192 11752352 10494996 22559224 16182939


    Sources:
    TdgClinicalTrial ChemblInteractions NCI TEND

  • BACLOFEN   FOS

    Interaction Score: 1.24

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11301212


    Sources:
    NCI

  • BACLOFEN   TSHB

    Interaction Score: 1.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    9408051


    Sources:
    NCI

  • BACLOFEN   GCG

    Interaction Score: 0.77

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    7042732


    Sources:
    NCI

  • BACLOFEN   TAC1

    Interaction Score: 0.56

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    2467977


    Sources:
    NCI

  • BACLOFEN   NOS1

    Interaction Score: 0.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16137704 15476754


    Sources:
    NCI

  • BACLOFEN   BDNF

    Interaction Score: 0.19

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17074039


    Sources:
    NCI

  • BACLOFEN   NFKB1

    Interaction Score: 0.07

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BACLOFEN   NFE2L2

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TdgClinicalTrial: BACLOFEN

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of alcohol dependance
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

  • TEND: BACLOFEN

    • Version: 01-August-2011

    Alternate Names:

    Drug Info:
    Drug Class muscle relaxants
    Year of Approval 1977

    Publications:

  • NCI: BACLOFEN

    • Version: 14-September-2017

    Alternate Names:
    C28858 NCI drug code

    Drug Info:

    Publications:
    Parramón et al., 1995, GABAB receptors increase intracellular calcium concentrations in chromaffin cells through two different pathways: their role in catecholamine secretion., J. Neurosci. Res.
    Seifert et al., 1998, Effects of baclofen on the Hering-Breuer inspiratory-inhibitory and deflation reflexes in rats., Am. J. Physiol.
    Hwang et al., 1989, Baclofen, gamma-aminobutyric acidB receptors and substance P in the mouse spinal cord., J. Pharmacol. Exp. Ther.

  • DTC: BACLOFEN

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL701 ChEMBL Drug ID

    Drug Info:

    Publications:

  • TTD: Baclofen

    • Version: 2020.06.01

    Alternate Names:
    D01AJY TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL701

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL701

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21